For more information or confidential assistance
800-306-3180
se habla español

Stephanie Reid

Stephanie Reid is a practicing attorney and writer. In her position as a staff writer for Drug Reporter, she is dedicated to raising consumer awareness about the dangers of both prescription and common over-the-counter products.

Is “Low T” a Real Condition? FDA Weighs In

Propecia erectile dysfunction patient
Over the past several years, the number of testosterone replacement therapy products prescribed to men approaching senior citizen status has literally soared – reaching sales topping $9 billion. The culprit? The apparent onset of the condition known as “low-t,” or low testosterone – a condition believed by some in the... Read more »

Xarelto Injury Lawsuit Alleges Wrongful death

The controversial blood thinning drug Xarelto has been named in yet another lawsuit – this time, tragically, following the death of an elderly Missouri resident who was prescribed the medication by his treating physician in December, 2012. Xarelto has been targeted with increasing scrutiny over the past several years, and... Read more »

AbbVie Looking for Further Delay in AndroGel Lawsuits

Presently, there are over 800 AndroGel lawsuits pending against manufacturer AbbVie, all of which are seeking compensation for expenses and damages incurred as a result of alleged side effects linked to the testosterone therapy. These claims, which have been consolidated along with other lesser-known claims against testosterone replacement products, are awaiting... Read more »

Risperdal Lawsuit Filed in Louisiana District Court

On March 27, 2015, a former Risperdal patient filed a lawsuit in U.S. District Court for the Eastern District of Louisiana against several drug manufacturers, including Janssen Pharmaceuticals and Johnson & Johnson. The complaint is one of several ongoing causes of action against the makers of the powerful antipsychotic drug, which... Read more »

Zofran Lawsuit Filed in Montana District Court

In a recent complaint against Zofran manufacturer GlaxoSmithKline (GSK), two Montana parents have alleged significant failures by GSK to properly warn women of the allegedly known risks of congenital birth defects in babies exposed to the drug in utero. The complaint includes the full history of the testing and approval of... Read more »

Intracranial Hemorrhage Subject of Xarelto Lawsuit

For patients suffering from the condition known as atrial fibrillation – or “A-fib” – an anti-coagulant drug is often used to help prevent the formation of deadly blood clots. For generations, doctors prescribed the drug known as warfarin to A-fib patients, until the newer blood thinning drug Xarelto was introduced... Read more »